Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Antibe update

<< Previous

Bullboard Posts

Next >>

Comment by wagyusteakon Dec 02, 2020 10:59am

131 Views

Post# 32017708

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Antibe update

Snowballgrowth wrote:

MrMugsy wrote: Very fair comments MJN.
I do hope that GUD finds a way to surprise positively ... but I'm not going to hold my breath.

My next big move into GUD will come from gains at ATE ... again ... I don't know if/when that will happen but I do believe in it.

My new money will flow into TherapeuticsMD and if I get lucky with gains ... it will flow into GUD as well.

A long process, it is.

Samira said it will take 6 months longer in LATAM ref Covid but I think they have to announce something on the BD front. Even potentials partners would like positive news for LATAM.